PHREESIA INC (PHR) Fundamental Analysis & Valuation

NYSE:PHR • US71944F1066

Current stock price

11.86 USD
+0.09 (+0.76%)
At close:
11.9 USD
+0.04 (+0.34%)
After Hours:

This PHR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. PHR Profitability Analysis

1.1 Basic Checks

  • PHR had negative earnings in the past year.
  • PHR had a positive operating cash flow in the past year.
  • In the past 5 years PHR always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: PHR reported negative operating cash flow in multiple years.
PHR Yearly Net Income VS EBIT VS OCF VS FCFPHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.27%, PHR is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -1.68%, PHR is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
Industry RankSector Rank
ROA -1.27%
ROE -1.68%
ROIC N/A
ROA(3y)-33.2%
ROA(5y)-26.37%
ROE(3y)-45.91%
ROE(5y)-35.28%
ROIC(3y)N/A
ROIC(5y)N/A
PHR Yearly ROA, ROE, ROICPHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 500 1K

1.3 Margins

  • PHR has a Gross Margin of 68.20%. This is in the better half of the industry: PHR outperforms 65.71% of its industry peers.
  • PHR's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for PHR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.16%
GM growth 5Y1.12%
PHR Yearly Profit, Operating, Gross MarginsPHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. PHR Health Analysis

2.1 Basic Checks

  • PHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for PHR has been increased compared to 1 year ago.
  • The number of shares outstanding for PHR has been increased compared to 5 years ago.
  • The debt/assets ratio for PHR is higher compared to a year ago.
PHR Yearly Shares OutstandingPHR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
PHR Yearly Total Debt VS Total AssetsPHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • PHR has an Altman-Z score of 2.91. This is not the best score and indicates that PHR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • PHR has a Altman-Z score of 2.91. This is in the better half of the industry: PHR outperforms 71.43% of its industry peers.
  • The Debt to FCF ratio of PHR is 0.27, which is an excellent value as it means it would take PHR, only 0.27 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.27, PHR is in the better half of the industry, outperforming 77.14% of the companies in the same industry.
  • PHR has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.01, PHR perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.27
Altman-Z 2.91
ROIC/WACCN/A
WACC9.58%
PHR Yearly LT Debt VS Equity VS FCFPHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 2.44 indicates that PHR has no problem at all paying its short term obligations.
  • PHR has a Current ratio (2.44) which is in line with its industry peers.
  • PHR has a Quick Ratio of 2.44. This indicates that PHR is financially healthy and has no problem in meeting its short term obligations.
  • PHR has a Quick ratio (2.44) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 2.44
PHR Yearly Current Assets VS Current LiabilitesPHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. PHR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 93.75% over the past year.
  • Looking at the last year, PHR shows a quite strong growth in Revenue. The Revenue has grown by 14.33% in the last year.
  • Measured over the past years, PHR shows a very strong growth in Revenue. The Revenue has been growing by 27.46% on average per year.
EPS 1Y (TTM)93.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
Revenue 1Y (TTM)14.33%
Revenue growth 3Y25.34%
Revenue growth 5Y27.46%
Sales Q2Q%12.67%

3.2 Future

  • The Earnings Per Share is expected to grow by 43.66% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 11.34% on average over the next years. This is quite good.
EPS Next Y116.89%
EPS Next 2Y62.42%
EPS Next 3Y43.66%
EPS Next 5YN/A
Revenue Next Year14.6%
Revenue Next 2Y14.82%
Revenue Next 3Y12.83%
Revenue Next 5Y11.34%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PHR Yearly Revenue VS EstimatesPHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
PHR Yearly EPS VS EstimatesPHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

4

4. PHR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PHR. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 18.23, the valuation of PHR can be described as rather expensive.
  • PHR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PHR is cheaper than 74.29% of the companies in the same industry.
  • PHR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.28.
Industry RankSector Rank
PE N/A
Fwd PE 18.23
PHR Price Earnings VS Forward Price EarningsPHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as PHR.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHR indicates a somewhat cheap valuation: PHR is cheaper than 68.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.38
EV/EBITDA 30.76
PHR Per share dataPHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • PHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • PHR's earnings are expected to grow with 43.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.42%
EPS Next 3Y43.66%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PHR Dividend Analysis

5.1 Amount

  • No dividends for PHR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHR Fundamentals: All Metrics, Ratios and Statistics

PHREESIA INC

NYSE:PHR (3/20/2026, 8:16:57 PM)

After market: 11.9 +0.04 (+0.34%)

11.86

+0.09 (+0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)12-08
Earnings (Next)03-30
Inst Owners100.77%
Inst Owner Change-3.57%
Ins Owners5.18%
Ins Owner Change6.18%
Market Cap715.04M
Revenue(TTM)463.20M
Net Income(TTM)-5.38M
Analysts84.17
Price Target28.62 (141.32%)
Short Float %7.06%
Short Ratio2.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8258.63%
Min EPS beat(2)115.6%
Max EPS beat(2)16401.7%
EPS beat(4)4
Avg EPS beat(4)4149.43%
Min EPS beat(4)38.81%
Max EPS beat(4)16401.7%
EPS beat(8)8
Avg EPS beat(8)2083.66%
EPS beat(12)12
Avg EPS beat(12)1396.19%
EPS beat(16)16
Avg EPS beat(16)1052.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.56%
Min Revenue beat(2)-0.76%
Max Revenue beat(2)-0.37%
Revenue beat(4)0
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-0.76%
Max Revenue beat(4)-0.18%
Revenue beat(8)1
Avg Revenue beat(8)-0.37%
Revenue beat(12)4
Avg Revenue beat(12)0.17%
Revenue beat(16)8
Avg Revenue beat(16)0.55%
PT rev (1m)-2%
PT rev (3m)-16.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)216.02%
EPS NY rev (1m)-0.89%
EPS NY rev (3m)648.18%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)1.44%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.23
P/S 1.54
P/FCF 20.38
P/OCF 11.64
P/B 2.23
P/tB 4.34
EV/EBITDA 30.76
EPS(TTM)-0.07
EYN/A
EPS(NY)0.65
Fwd EY5.49%
FCF(TTM)0.58
FCFY4.91%
OCF(TTM)1.02
OCFY8.59%
SpS7.68
BVpS5.31
TBVpS2.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.27%
ROE -1.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.2%
FCFM 7.58%
ROA(3y)-33.2%
ROA(5y)-26.37%
ROE(3y)-45.91%
ROE(5y)-35.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.16%
GM growth 5Y1.12%
F-Score7
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.27
Debt/EBITDA 0.17
Cap/Depr 92.06%
Cap/Sales 5.68%
Interest Coverage N/A
Cash Conversion 308.26%
Profit Quality N/A
Current Ratio 2.44
Quick Ratio 2.44
Altman-Z 2.91
F-Score7
WACC9.58%
ROIC/WACCN/A
Cap/Depr(3y)91.68%
Cap/Depr(5y)107.3%
Cap/Sales(3y)7.37%
Cap/Sales(5y)9.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
EPS Next Y116.89%
EPS Next 2Y62.42%
EPS Next 3Y43.66%
EPS Next 5YN/A
Revenue 1Y (TTM)14.33%
Revenue growth 3Y25.34%
Revenue growth 5Y27.46%
Sales Q2Q%12.67%
Revenue Next Year14.6%
Revenue Next 2Y14.82%
Revenue Next 3Y12.83%
Revenue Next 5Y11.34%
EBIT growth 1Y89.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year266.23%
EBIT Next 3Y65.6%
EBIT Next 5Y38.03%
FCF growth 1Y150.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y235.86%
OCF growth 3YN/A
OCF growth 5Y108.09%

PHREESIA INC / PHR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PHREESIA INC?

ChartMill assigns a fundamental rating of 4 / 10 to PHR.


What is the valuation status of PHREESIA INC (PHR) stock?

ChartMill assigns a valuation rating of 4 / 10 to PHREESIA INC (PHR). This can be considered as Fairly Valued.


Can you provide the profitability details for PHREESIA INC?

PHREESIA INC (PHR) has a profitability rating of 2 / 10.


What is the expected EPS growth for PHREESIA INC (PHR) stock?

The Earnings per Share (EPS) of PHREESIA INC (PHR) is expected to grow by 116.89% in the next year.


Can you provide the dividend sustainability for PHR stock?

The dividend rating of PHREESIA INC (PHR) is 0 / 10 and the dividend payout ratio is 0%.